-
The 15th International Genomics Congress opened in Wuhan
Time of Update: 2021-03-13
ICG has always been a major life medicine and life science and technology industry progress in China as an important research topic, through the academic industry discussion of this conference, for the future of the new crown epidemic prevention and control to provide professional insights, for the future control and development of advice.
-
Medopad completes $25 million B round of financing
Time of Update: 2021-03-02
Nov. 6 (Xinhua) -- Mobile healthcare company Medopad announced the completion of a $25 million round of B financing.
In addition, Bayer will work with Medopad to develop digital biomarker diagnostics to improve human heart health.
-
Shanxi started the performance appraisal of the three-level public hospital
Time of Update: 2021-02-21
, shanxi provincial government office issued "on the implementation of the province's three-level public hospital performance appraisal notice." "Notice" clearly, in 2019 in the province to start the
-
China has officially joined the "New Crown Vaccine Implementation Program", Ministry of Foreign Affairs announces
Time of Update: 2021-02-15
3, at a regular press conference at the Ministry of Foreign Affairs, spokesman Wang Wenbin said that China has officially joined the "New Crown Vaccine Implementation Plan" and maintained close communication with WHO and other sponsors to work together to make vaccines a global public product and achieve accessibility and affordability for developing countries.
-
Science: The day before Lilly, Regenerative Meta announced the effects of the antibody, Science sent a paper saying that the mutant strain may have evaded the treatment of the antibody
Time of Update: 2021-02-02
based on this library of viral mutants, the researchers focused on how mutations in SARS-CoV-2 RBD that do not strongly destroy the combination with ACE-2 affect reGN10933, REGN10987, LY-CoV016, and REGN10933 and REGN10987 combination therapies, and use spike prosthetic slow virus particles to verify the effects of key mutations.
-
What does the UK think of the EU and the US taking the lead in authorizing Pfizer's new crown vaccine
Time of Update: 2020-12-13
The Department of Health and Social Security said the provisional approval came after "months of rigorous clinical trials and a thorough analysis of the data by MHRA experts in the UK, which concluded
-
Profit announcement! Top 70 domestic arms companies are coming (with list
Time of Update: 2020-11-17
, profit ranking in the first half of 2020 domestic A-share listed enterprises overall rose.
end of August 2020, the total revenue of 71 domestic A-share enterprises was 83.5 billion yuan, up about 44% YoY, and the total net profit was 22.66 billion yuan, up 34% YoY.
-
The first domestic trastuzumab is included in Shanghai Medical Insurance, and the individual pays 670 yuan/bottle
Time of Update: 2020-10-02
Medical network September 18, recently, the Shanghai Medical Insurance Bureau issued a message, will be Fuhong Hanyu Quzhu single anti-injection into the city's medical insurance, the insured person's
-
HIV Infection Emergency Listed HIV-1 Protease Inhibitor Overview
Time of Update: 2020-09-28
the FDA currently lists 10 anti-HIV-1 protease inhibitors, including: Saquinavir (Saquinavir, SQV), Ritonavir (Litonavi, RTV), Indinavir ( Dinave, IDV), Nelfinavir (Nifinavir, NFV), Amprenavir (Ampnavir, APV), Fosamprenavir (Fosanawe, Fos-APV), Lopinavir (Lopinave, LPV), Atazanavir (Azanavi, ATV), Tipranavir (TPV) and Darunavir (Darunawe, DRV).
-
2020 NMN industry trend analysis, the broader the market more focus on safety and scientific research
Time of Update: 2020-09-16
product safety and scientific research strength leading the NMN industry NMN brand, such as cow hair, but also chaos from the birth, in such a complex environment can break out, consumers' eyes and the strength of the business is equally important.
-
Clinica Chimica Acta: Effects of COVID-19 on blood
Time of Update: 2020-08-21
the initial clinical characteristics of SARS-CoV-2 infection are nonseal, and not all suspected patients can be tested to rule out or confirm a diagnosis.
-
Sun Tzu: From "research services" to "health medicine", the way to expand the gene sequencing enterprises
Time of Update: 2020-08-11
now, as the chairman of Shanghai Passenno Biotech Co., Ltd., he led the company to improve the construction of a sequencing platform from one generation to three generations, realize the new three-board listing, complete the transformation from scientific research services to health medicine, successfully set up a medical testing institute, into the National Health Care Big Data (Nanjing) Center ...
-
A selection of BMJ research highlights from July 18, 2020
Time of Update: 2020-07-27
!---- Prediabetes increases the risk of cardiovascular disease, especially in patients with a history of atherosclerosis: https://doi.org/10.1136/bmj.m2297, researchers recently examined the relations
-
New! 14 clinically in short supply of drugs for online procurement
Time of Update: 2020-07-15
Guide: Why are clinical shortages frequently? June 30, Shanghai Sunshine Pharmaceutical Procurement Network issued a notice, announced the dixitox injection and other clinical shortage of drugs on-li
-
Nohui Health receives $30 million E-round financing to complete large-scale prospective multi-center clinical trial of China's first early cancer screening product ahead of schedule
Time of Update: 2020-07-10
Guide: Nohui Health Financing has been successful again, and early cancer screening has attracted much attention on July 10, , Nohuco Health, China's first bio-high-tech company focused on early canc
